Intestinal ultrasound monitors therapeutic response in IBD, inpatient opioids tied to future use — top stories in gastroenterology
Click Here to Manage Email Alerts
Researchers found that using an intestinal ultrasound to assess bowel wall thickness can help monitor treatment response in patients with ulcerative colitis. This was one of the top stories in gastroenterology last week.
A study that found patients with inflammatory bowel disease who received opioids while hospitalized were more likely to be exposed to opioids after discharge was another top story.
Intestinal ultrasound helps monitor response in ulcerative colitis
Assessing bowel wall thickness with intestinal ultrasound can be a helpful tool to monitor therapeutic response in patients with ulcerative colitis, according to study results published in Gut. Read more.
Inpatient opioids linked with future opioid use in IBD
Patients with inflammatory bowel disease who received intravenous or non-intravenous opioids while in the hospital are more likely to be exposed to opioids after they are discharged, according to researchers. Read more.
Treat-to-target measured by ultrasonography linked with better Crohn’s outcomes
Small intestine contrast ultrasonographic assessment of mucosal healing can be an effective method to gauge response to anti-TNF therapy among patients with Crohn’s disease, according to study results. Read more.
Dysbiosis from H. pylori infection may be involved in gastric carcinogenesis
Microbial dysbiosis caused by Helicobacter pylori infection may be an important driver in the development of gastric cancer, according to researchers. Read more.
Early VTE linked with worse survival in pancreatic ductal adenocarcinoma
Frequent and early onset of venous thromboembolism are associated with decreased progression-free survival and overall survival among patients diagnosed with pancreatic ductal adenocarcinoma, according to study results. Read more.